|
Visual inspection: during the visual inspection a deformation of the outer housing of the progav could be determined.The measurement of the plane parallelism could confirm that with a value of -0,030 mm - outside tolerance (0 ± 0.02 mm).Permeability test: a permeability test has indicated that the progav is permeable while the shuntassistant has a blockage.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.The results show that the progav is operating not within the accepted tolerance in the horizontal position.Accelerated outflow was determined during our measurement.Due to the non-permeability of the shuntsassistant, a measurement on the test bench could not be performed.Adjustment test: the progav was tested and is not adjustable.Braking force and brake function test: the brake functionality test has shown that the brake function is operational, however the braking force cannot be measured due to the non-adjustability of the valve.Internal inspection: after dismantling of the valves, deposits were found in both valves.To make the proteins / deposits in the shunt system more visible, they were colored using a staining solution.Results: based on our investigation results, we can determine, at the time of our investigation, accelerated outflow on the progav, a blockage on the shuntassistant, and deposits on both valves.The cause for the malfunctions mentioned could be the deposits found.Proteins in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|